PDL BIOPHARMA INC's ticker is and the CUSIP is 69329Y954. A total of 2 filers reported holding PDL BIOPHARMA INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $3,000 | 0.0% | 1,100 | 0.0% | 0.00% | – |
| Q2 2018 | $3,000 | -92.3% | 1,100 | -91.6% | 0.00% | – |
| Q1 2018 | $39,000 | +14.7% | 13,100 | +6.5% | 0.00% | – |
| Q4 2017 | $34,000 | -83.6% | 12,300 | -79.9% | 0.00% | -100.0% |
| Q3 2017 | $207,000 | – | 61,200 | +30500.0% | 0.00% | – |
| Q2 2017 | $0 | -100.0% | 200 | -96.5% | 0.00% | – |
| Q1 2017 | $13,000 | +85.7% | 5,700 | +72.7% | 0.00% | – |
| Q4 2016 | $7,000 | -93.1% | 3,300 | -89.8% | 0.00% | -100.0% |
| Q2 2016 | $101,000 | -56.3% | 32,200 | -53.6% | 0.00% | -66.7% |
| Q1 2016 | $231,000 | +3750.0% | 69,400 | +6209.1% | 0.00% | – |
| Q3 2015 | $6,000 | -64.7% | 1,100 | -57.7% | 0.00% | – |
| Q2 2015 | $17,000 | -78.8% | 2,600 | -77.2% | 0.00% | -100.0% |
| Q1 2015 | $80,000 | +3.9% | 11,400 | +14.0% | 0.00% | 0.0% |
| Q4 2014 | $77,000 | -42.5% | 10,000 | -44.4% | 0.00% | -50.0% |
| Q3 2014 | $134,000 | +346.7% | 18,000 | +480.6% | 0.00% | – |
| Q2 2014 | $30,000 | -42.3% | 3,100 | -50.0% | 0.00% | -100.0% |
| Q1 2014 | $52,000 | +52.9% | 6,200 | +55.0% | 0.00% | 0.0% |
| Q4 2013 | $34,000 | -80.1% | 4,000 | -81.3% | 0.00% | -66.7% |
| Q3 2013 | $171,000 | -5.0% | 21,400 | -8.2% | 0.00% | -25.0% |
| Q2 2013 | $180,000 | – | 23,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIMPLEX TRADING, LLC | 2 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |